title: eComment: Stage IIIA-N2 non-small cell lung cancer: could a new scoring system improve the management of heterogeneous disease?
authors.affiliation: Department of General Thoracic Surgery, Catholic University of Rome, Rome, Italy.
authors.forename: Filippo
authors.initials: F
authors.lastname: Lococo
authors.forename: Giovanni
authors.initials: G
authors.lastname: Leuzzi
authors.forename: Stefano
authors.initials: S
authors.lastname: Cafarotti
authors.forename: Stefano
authors.initials: S
authors.lastname: Margaritora
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000145:classification / Q000401:mortality / Q000556:secondary* / Q000601:surgery; D018572:Disease-Free Survival; D006801:Humans; D008175:Lung Neoplasms / Q000145:classification / Q000401:mortality / Q000473:pathology* / Q000601:surgery; D008197:Lymph Node Excision; D008198:Lymph Nodes / Q000473:pathology* / Q000601:surgery; D008207:Lymphatic Metastasis; D009367:Neoplasm Staging; D011013:Pneumonectomy; D011237:Predictive Value of Tests; D015203:Reproducibility of Results; D018570:Risk Assessment; D012307:Risk Factors; D015996:Survival Rate; D013997:Time Factors; D016896:Treatment Outcome